查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594481

神经血栓清除装置市场：依产品、治疗应用及最终用途 – 2025-2030 年全球预测

Neurothrombectomy Devices Market by Product, Therapeutic Application (Arteriovenous Malformations & AV Fistulas, Cerebral Aneurysms, Cerebral Artery Stenosis), End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年神经血栓切除设备市场价值为7.8001亿美元，预计到2024年将达到8.75亿美元，复合年增长率为12.66%，预计到2030年将达到17.9713亿美元。

神经血栓切除装置对于治疗急性缺血性脑中风至关重要，用于物理清除脑动脉中的血栓。由于人口老化以及糖尿病和高血压等与文明病的增加，全球中风的发病率不断增加，因此这一点的必要性得到了强调。其应用范围扩展到医院和神经科科诊所等医疗机构，最终用户是专门从事神经病学和介入放射学的医疗专业人员。市场成长主要由技术进步推动，例如开发具有更高准确性和安全性的下一代检索器和抽吸装置。最近，政府加大对中风管理的支持和有利的报销政策提供了有利可图的机会。然而，该市场因设备和程序的高成本以及缺乏熟练的专业人员来操作而受到阻碍，特别是在新兴市场。机会在于开拓具有成本效益的解决方案并扩大进入亚洲和非洲开拓市场的机会。该领域的创新可以集中在设备小型化上，以提高可操作性，以及开发人工智慧驱动的诊断和手术工具，以支援快速、准确地清除血栓。市场相关人员还应考虑与政府机构和医疗保健组织合作，加强对临床医生的培训计画。然而，来自药物溶栓等替代疗法的竞争以及严格的监管政策是持续的挑战。儘管面临这些挑战，在持续的研发投资和策略伙伴关係关係的推动下，神经血栓切除术市场预计将显着成长。创新者应专注于提高设备功效和患者治疗效果，还可以探索奈米技术和生物感测器的整合。总体而言，市场是动态的，具有巨大的创新和策略性扩张空间，以满足对改善中风治疗和介入措施不断增长的需求。

主要市场统计
基准年[2023] 78001万美元
预测年份 [2024] 8.75 亿美元
预测年份 [2030] 1,797.13 百万美元
复合年增长率（%） 12.66%

市场动态：揭示快速发展的神经血栓清除设备市场的关键市场洞察

供需的动态交互作用正在改变神经血栓切除术设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球急性缺血性脑中风增加
    • 世界各国政府为预防中风所做的努力
    • 提高大众对神经血栓切除的认识
  • 市场限制因素
    • 严格而复杂的法律规范
  • 市场机会
    • 扩大先进神经血栓清除装置的开发
    • 市场参与企业增加投资和赎回政策的可用性
  • 市场问题
    • 与神经血栓切除装置相关的风险

波特五力：驾驭神经血栓切除设备市场的策略工具

波特的五力框架是了解神经血栓切除设备市场竞争格局的关键工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解神经血栓清除设备市场的外部影响

外部宏观环境因素在塑造神经血栓切除设备市场的绩效动态发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析：了解神经血栓切除设备市场的竞争状况

对神经血栓切除术设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：神经血栓切除设备市场供应商的绩效评估

FPNV 定位矩阵是评估神经血栓切除设备市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製神经血栓清除设备市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对神经血栓切除术设备市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1. 市场渗透率：详细检视当前市场环境，主要企业的广泛资料，评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球急性缺血性脑中风的发生率增加
      • 世界各国政府为预防中风所做的努力
      • 提高大众对神经血栓切除的认识
    • 抑制因素
      • 严格而复杂的法规结构
    • 机会
      • 扩大先进神经血栓切除设备的开发
      • 市场参与企业增加投资和赎回政策的可用性
    • 任务
      • 与神经血栓切除装置相关的风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章神经血栓切除设备市场：副产品

  • 介绍
  • 吸引装置
  • 凝结猎犬
  • 勒除器

第七章神经血栓清除装置市场：依治疗应用分类

  • 介绍
  • 动静脉畸形 (AVM) 和 AV 瘻管
  • 脑动脉瘤
  • 脑动脉狭窄
  • 缺血性中风

第八章神经血栓清除装置市场：依最终用途分类

  • 介绍
  • 门诊手术中心
  • 急诊室
  • 医院

第九章北美及南美神经血栓清除装置市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太神经血栓切除术设备市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲/中东/非洲神经血栓切除术设备市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Acandis GmbH
  • Argon Medical Devices, Inc.
  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV
  • Medtronic Plc
  • NeuroVasc Technologies, Inc.
  • Penumbra, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • Vesalio, LLC
Product Code: MRR-8C74ADFC1598

The Neurothrombectomy Devices Market was valued at USD 780.01 million in 2023, expected to reach USD 875.00 million in 2024, and is projected to grow at a CAGR of 12.66%, to USD 1,797.13 million by 2030.

Neurothrombectomy devices are integral in the treatment of acute ischemic strokes, employed to physically remove blood clots from cerebral arteries. The necessity of these devices is underscored by the rising incidence of strokes globally, coupled with an aging population and increasing prevalence of lifestyle diseases like diabetes and hypertension. Their application spans healthcare facilities such as hospitals and specialty neurology clinics, with end-users being healthcare professionals specializing in neurology and interventional radiology. Market growth is primarily driven by advancements in technology, including the development of next-generation retrievers and aspiration devices that offer increased precision and safety. Recently, increasing government support for stroke management, alongside favorable reimbursement policies, presents lucrative opportunities. However, market constraints include the high cost of devices and procedures, coupled with a dearth of skilled professionals to operate them, especially in developing regions. Opportunities lie in developing cost-effective solutions and expanding reach to untapped markets in Asia and Africa. Innovations in the field may focus on miniaturization of devices for enhanced maneuverability and development of AI-powered diagnostic and surgical tools to support swift and precise clot removal. Market players should also consider collaboration with government bodies and health organizations to enhance training programs for clinicians. Nonetheless, stringent regulatory policies pose ongoing challenges, alongside the competition from alternative therapies like pharmacological thrombolysis. Despite these challenges, the neurothrombectomy market is expected to witness substantial growth, fueled by continuous R&D investments and strategic partnerships. Innovators should focus on improving device efficacy and patient outcomes, potentially exploring the integration of nanotechnology and biosensor advancements. Overall, the market is dynamic, with substantial scope for innovation and strategic expansion to cater to the growing demand for improved stroke treatments and interventions.

KEY MARKET STATISTICS
Base Year [2023] USD 780.01 million
Estimated Year [2024] USD 875.00 million
Forecast Year [2030] USD 1,797.13 million
CAGR (%) 12.66%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurothrombectomy Devices Market

The Neurothrombectomy Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidences of acute ischemic stroke globally
    • Initiatives by government worldwide for the prevention of stroke
    • Growing awareness about the neurothrombectomy among the population
  • Market Restraints
    • Stringent and complex regulatory framework
  • Market Opportunities
    • Growing development of advanced neurothrombectomy devices
    • Increasing investments by market players and availability of reimbursement policies
  • Market Challenges
    • Risks associated with the neurothrombectomy devices

Porter's Five Forces: A Strategic Tool for Navigating the Neurothrombectomy Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurothrombectomy Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurothrombectomy Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurothrombectomy Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurothrombectomy Devices Market

A detailed market share analysis in the Neurothrombectomy Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurothrombectomy Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurothrombectomy Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurothrombectomy Devices Market

A strategic analysis of the Neurothrombectomy Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurothrombectomy Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acandis GmbH, Argon Medical Devices, Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., Medtronic Plc, NeuroVasc Technologies, Inc., Penumbra, Inc., Stryker Corporation, Teleflex Incorporated, Terumo Corporation, and Vesalio, LLC.

Market Segmentation & Coverage

This research report categorizes the Neurothrombectomy Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Aspiration/Suction Devices, Clot Retrievers, and Vascular Snares.
  • Based on Therapeutic Application, market is studied across Arteriovenous Malformations (AVMs) & AV Fistulas, Cerebral Aneurysms, Cerebral Artery Stenosis, and Ischemic Stroke.
  • Based on End-Use, market is studied across Ambulatory Surgical Centers, Emergency Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidences of acute ischemic stroke globally
      • 5.1.1.2. Initiatives by government worldwide for the prevention of stroke
      • 5.1.1.3. Growing awareness about the neurothrombectomy among the population
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent and complex regulatory framework
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing development of advanced neurothrombectomy devices
      • 5.1.3.2. Increasing investments by market players and availability of reimbursement policies
    • 5.1.4. Challenges
      • 5.1.4.1. Risks associated with the neurothrombectomy devices
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurothrombectomy Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Aspiration/Suction Devices
  • 6.3. Clot Retrievers
  • 6.4. Vascular Snares

7. Neurothrombectomy Devices Market, by Therapeutic Application

  • 7.1. Introduction
  • 7.2. Arteriovenous Malformations (AVMs) & AV Fistulas
  • 7.3. Cerebral Aneurysms
  • 7.4. Cerebral Artery Stenosis
  • 7.5. Ischemic Stroke

8. Neurothrombectomy Devices Market, by End-Use

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Emergency Clinics
  • 8.4. Hospitals

9. Americas Neurothrombectomy Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Neurothrombectomy Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Neurothrombectomy Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Acandis GmbH
  • 3. Argon Medical Devices, Inc.
  • 4. Boston Scientific Corporation
  • 5. Edwards Lifesciences Corporation
  • 6. Johnson & Johnson Services, Inc.
  • 7. Koninklijke Philips N.V.
  • 8. Medtronic Plc
  • 9. NeuroVasc Technologies, Inc.
  • 10. Penumbra, Inc.
  • 11. Stryker Corporation
  • 12. Teleflex Incorporated
  • 13. Terumo Corporation
  • 14. Vesalio, LLC

LIST OF FIGURES

  • FIGURE 1. NEUROTHROMBECTOMY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROTHROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROTHROMBECTOMY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ASPIRATION/SUCTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CLOT RETRIEVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY VASCULAR SNARES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS (AVMS) & AV FISTULAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY EMERGENCY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM NEUROTHROMBECTOMY DEVICES MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 147. NEUROTHROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. NEUROTHROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023